Nintedanib(OFEV)

Release date: 2026-01-05 14:05:31     Recommended: 26

It is indicated for the treatment of idiopathic pulmonary fibrosis (IPF), chronic fibrosing interstitial lung disease (ILD), and systemic sclerosis-associated interstitial lung disease (SSc-ILD) in ad